Under the leadership of Dr. Monty Ghosh and Dr. Ken Lee, the CSAM-SMCA Online Journal Club provides an opportunity for Canadian addiction medicine practitioners to discuss new research and emerging best practices in their chosen field.
Each month, two journal articles are selected and sent to participants via email. During the Online Journal Club Zoom meetings, each article is summarized by a presenter, followed by a discussion with the participants examining the study design, conclusions and potential application to clinical practice. Each hour-long session is facilitated by Dr. Ghosh and/or Dr. Lee.
The objective of the Journal Club is to raise awareness about emerging topics in addiction medicine, and to encourage connection, discussion and debate among colleagues across Canada. There is no cost to participate, and the Journal Club is open to anyone who is interested in or practicing addiction medicine, including those who are not members of CSAM-SMCA. We encourage trainee members and other participants to present articles at the sessions, please contact if you are interested in presenting.
September 08, 2022 @ 6:00 PM MST
October 13, 2022 @ 6:00 PM MST
November 10, 2022 @ 6:00 PM MST
Dr. Monty Ghosh
Internist and Addiction Specialist, University of Alberta Hospital, Edmonton, Alberta
CSAM-SMCA Board of Directors — IT Liaison
Dr. Ken Lee
Medical Director, RAAM Clinic, London, Ontario
CSAM-SMCA Board of Directors — Ontario Regional Director
Articles Reviewed at Previous Online Journal Club Sessions
Harris M, Joseph K, Hoeppner B, et al. A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2021 Jul-Aug 01;15(4):311-317. doi: 10.1097/ADM.0000000000000761.
Lehmann K, Kuhn S, Baschirotto C, et al. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine. J Subst Abuse Treat. 2021; Aug127:108350. doi: 10.1016/j.jsat.2021.108350.
Fine DR, Lewis E, Weinstock K, et al. Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness. JAMA Netw Open. 2021; Mar 1;4(3). doi: 10.1001/jamanetworkopen.
Xu KY, Borodovsky JT, Presnall N, et al. Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. Am J Psychiatry. 2021; Jul178(7):651-659. doi: 10.1176/appi.ajp.2020.20081174.
Fluyau D, Revadigar N, Pierre CG. Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder. Am J Addict. 2021 Mar;30(2):110-121. doi: 10.1111/ajad.13133.
Dennis BB, Sanger N, Bawor M, et al. A Call For Consensus In Defining Efficacy In Clinical Trials For Opioid Addiction: Combined Results From A Systematic Review And Qualitative Study In Patients Receiving Pharmacological Assisted Therapy For Opioid Use Disorder. Trials. 2020;21(20). doi: 10.1186/s13063-019-3995-y.
Trevedi MH, Walker R, Ling W, et. al. Bupropion And Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021;384:140-153. doi:10.1056/NEJMoa2020214.
Herring AA, Vosooghi AA, & Luftig, PA. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7). doi:10.1001/jamanetworkopen.2021.17128.
Englander H, King C, Nicolaidis C, et al. Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen By An Inpatient Addiction Consult Service. J Addict Med. 2020;Sep/Oct;14(5):415-422. doi: 10.1097/ADM.0000000000000611.